The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.125
Bid: 0.11
Ask: 0.14
Change: 0.00 (0.00%)
Spread: 0.03 (27.273%)
Open: 0.125
High: 0.125
Low: 0.125
Prev. Close: 0.125
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

19 Apr 2011 13:25

RNS Number : 1871F
Deltex Medical Group PLC
19 April 2011
 



Deltex Medical Group plc

 

Grant of options

 

19 April 2011 - Deltex Medical Group plc (the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that today the Board approved the issue of share options to Ewan Phillips, Chief Executive.

 

EMI scheme - salary sacrifice

 

Following his appointment as Chief Executive in September 2009, the Company's remuneration committee awarded Ewan Phillips a salary increase of £15,000 per annum. Mr Phillips has elected to sacrifice the whole of this salary increase in respect of the period 1 January 2011 to 31 March 2011, in return for awards of options under the Company's 2003 Enterprise Management Incentive ("EMI") Scheme as follows:

 

Name

Number

Exercise

Price £

Exercise period

Total Number of EMI options held

Ewan Phillips

13,636

0.01

2010 - 2021

2,922,376

 

 

Additional interests

 

Mr Phillips has a beneficial interest in 1,159,773 ordinary shares in the Company representing 0.84 per cent of the issued ordinary share capital of the Company. Mr Phillips also holds options over 2,480,000 shares in the Company's Employee share option scheme. These options have a range of exercise periods from 2004 to 2019.

 

All shares and options relate to ordinary shares of 1p each.

 

For further information, please contact:-

Deltex Medical Group plc 01243 774 837Nigel Keen, Chairman Ewan Phillips, Chief Executive Paul Mitchell, Finance Director

Nominated Adviser and Broker 020 7614 5917

Arden Partners plc 

Christopher Hardie

Jamie Cameron

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESFLFEUFFSEEL
Date   Source Headline
8th Apr 20245:03 pmRNSHolding(s) in Company
8th Apr 20247:00 amRNSPosting of Annual Report & Notice of AGM
28th Mar 20247:00 amRNSResults for the year ended 31 December 2023
2nd Feb 20245:11 pmRNSHolding(s) in Company
31st Jan 20245:00 pmRNSTotal Voting Rights
18th Jan 20245:01 pmRNSIssue of Equity
18th Jan 20247:00 amRNSYear-end trading update
4th Dec 20237:00 amRNSCommercial update, board changes & new auditor
18th Sep 20237:00 amRNSInterim results to 30 June 2023
31st Aug 20235:00 pmRNSTotal Voting Rights
2nd Aug 20236:23 pmRNSHolding(s) in Company
2nd Aug 20235:32 pmRNSHolding(s) in Company
2nd Aug 20238:00 amRNSFundraising completion, trading restoration & TVR
2nd Aug 20237:30 amRNSRestoration - Deltex Medical Group PLC
1st Aug 202310:04 amRNSResult of General Meeting
24th Jul 20237:00 amRNSResult of Retail Offer
18th Jul 20234:47 pmRNSExtension of Retail Offer Closing Time
14th Jul 20236:03 pmRNSRetail offer to raise up to £500,000
14th Jul 20236:01 pmRNSPlacing, Subscription and Retail Offer
10th Jul 20237:00 amRNSRelease of new next generation TrueVue System
6th Jul 20237:13 amRNSHalf-year Trading Update & Potential Fundraise
26th Jun 20237:30 amRNSSuspension - Deltex Medical Group PLC
26th Jun 20237:00 amRNSTrading update and suspension of trading on AIM
19th May 20231:35 pmRNSHolding(s) in Company
17th May 20233:24 pmRNSResult of AGM
17th May 20237:00 amRNSChairman’s Statement to the Annual General Meeting
28th Apr 20235:00 pmRNSTotal Voting Rights
25th Apr 20237:00 amRNSNew monitor launch update & new loan facility
11th Apr 20235:43 pmRNSIssue of Equity
30th Mar 20237:00 amRNSResults for the year ended 31 December 2022
27th Feb 20237:00 amRNSConvertible loan notes repayment date extension
24th Jan 20237:00 amRNSYear end trading update
22nd Dec 20227:00 amRNSYear end update
20th Sep 20227:00 amRNSInterim Results
14th Jul 20227:00 amRNSCompletion of Nominated Adviser due diligence
7th Jul 20227:00 amRNSHalf year trading update
18th May 20223:41 pmRNSResult of AGM
18th May 20227:00 amRNSChairman's Statement to Annual General Meeting
28th Apr 20227:00 amRNSChange of Adviser
7th Apr 20227:00 amRNSResults for the year ended 31 December 2021
2nd Mar 20224:30 pmRNSHolding(s) in Company
17th Feb 20224:02 pmRNSGrant of options
8th Feb 20227:00 amRNSSubscription and extension of Debt Facility
26th Jan 20227:00 amRNSContract win in the Americas
12th Jan 20227:00 amRNSIssue of Equity
11th Jan 20227:00 amRNSPre-close statement
20th Dec 20217:00 amRNSSuccessful Innovate UK Smart Award
20th Sep 20217:00 amRNSInterim results to 30 June 2021
22nd Jul 20213:48 pmRNSIssue of Equity
16th Jul 20217:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.